John Weston named chief operating officer of the Prostate Cancer Foundation

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

JOHN WESTON was named chief operating officer and executive vice president of the Prostate Cancer Foundation.

Most recently Weston served as public affairs department chair and chief marketing officer for the Mayo Clinic. He began his career at Mars Inc., held senior leadership positions at FedEx and was the chief marketing and corporate development officer for a valuation firm in Los Angeles.

Weston served on Mayo Clinic’s Board of Governors and was executive director of the clinic’s Office of Brand Management. He also served on the board of the Paralysis Project of America and was on the advisory boards of the Marriott School of Management, Brigham Young University and the University of Arkansas Walton School of Business.

Table of Contents

YOU MAY BE INTERESTED IN

The rapid adoption of glucagon-like peptide-1 receptor agonists (GLP-1RAs), particularly for weight management, represents one of the most significant shifts in metabolic medicine in decades. With millions of people now using medications such as semaglutide and tirzepatide, we are witnessing a fundamental alteration in patient physiology that extends far beyond glucose control and weight loss. As these drugs approach 10% population penetrance in some demographics, the oncology community faces an urgent question: How will this metabolic transformation reshape cancer care?

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login